Neither age, gender, nor the presence of thyroid dysfunction remained independently significant after adjusting for PD-L1, although thyroid dysfunction showed a trend toward a favorable hazard ratio.
← all excerpts
Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study.
1
—
—